Follow
Robert Kratzke
Robert Kratzke
Verified email at umn.edu
Title
Cited by
Cited by
Year
A genomic strategy to refine prognosis in early-stage non–small-cell lung cancer
A Potti, S Mukherjee, R Petersen, HK Dressman, A Bild, J Koontz, ...
New England Journal of Medicine 355 (6), 570-580, 2006
7012006
Human lung carcinomas express Fas ligand
GA Niehans, T Brunner, SP Frizelle, JC Liston, CT Salerno, DJ Knapp, ...
Cancer research 57 (6), 1007-1012, 1997
5391997
Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.
GA Otterson, RA Kratzke, A Coxon, YW Kim, FJ Kaye
Oncogene 9 (11), 3375-3378, 1994
5021994
The pathogenesis of mesothelioma
M Carbone, RA Kratzke, JR Testa
Seminars in oncology 29 (1), 2-17, 2002
4872002
ERCC1 isoform expression and DNA repair in non–small-cell lung cancer
L Friboulet, KA Olaussen, JP Pignon, FA Shepherd, MS Tsao, S Graziano, ...
New England Journal of Medicine 368 (12), 1101-1110, 2013
4272013
Video-assisted thoracoscopic surgery is more favorable than thoracotomy for resection of clinical stage I non-small cell lung cancer
BA Whitson, RS Andrade, A Boettcher, R Bardales, RA Kratzke, ...
The Annals of thoracic surgery 83 (6), 1965-1970, 2007
4132007
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non–small-cell lung cancer in four trials of …
FA Shepherd, C Domerg, P Hainaut, PA Jänne, JP Pignon, S Graziano, ...
Journal of clinical oncology 31 (17), 2173, 2013
3612013
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB …
PA Jänne, X Wang, MA Socinski, J Crawford, TE Stinchcombe, L Gu, ...
Journal of clinical oncology 30 (17), 2063, 2012
332*2012
Rb and p16INK4a Expression in Resected Non-Small Cell Lung Tumors
RA Kratzke, TM Greatens, JB Rubins, MA Maddaus, DE Niewoehner, ...
Cancer research 56 (15), 3415-3420, 1996
3301996
Prognostic effect of tumor lymphocytic infiltration in resectable non–small-cell lung cancer
E Brambilla, G Le Teuff, S Marguet, S Lantuejoul, A Dunant, S Graziano, ...
Journal of clinical oncology 34 (11), 1223, 2016
3242016
Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
R Govindan, RA Kratzke, JE Herndon, GA Niehans, R Vollmer, D Watson, ...
Clinical Cancer Research 11 (6), 2300-2304, 2005
3062005
Immunohistochemical Detection of the Cyclin-dependent Kinase Inhibitor 2/Multiple Tumor Suppressor Gene 1 (CDKN2/MTS1) Product p16INK4A in Archival …
J Geradts, RA Kratzke, GA Niehans, CE Lincoln
Cancer research 55 (24), 6006-6011, 1995
2901995
Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection
MS Tsao, S Marguet, G Le Teuff, S Lantuejoul, FA Shepherd, L Seymour, ...
Journal of clinical oncology 33 (30), 3439, 2015
2832015
A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding.
FJ Kaye, RA Kratzke, JL Gerster, JM Horowitz
Proceedings of the National Academy of Sciences 87 (17), 6922-6926, 1990
2751990
Tumor mutation burden as a biomarker in resected non–small-cell lung cancer
S Devarakonda, F Rotolo, MS Tsao, I Lanc, E Brambilla, A Masood, ...
Journal of Clinical Oncology 36 (30), 2995, 2018
2302018
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma
R Jagadeeswaran, PC Ma, TY Seiwert, S Jagadeeswaran, O Zumba, ...
Cancer research 66 (1), 352-361, 2006
2272006
Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non–small-cell lung cancer …
R Govindan, J Bogart, T Stinchcombe, X Wang, L Hodgson, R Kratzke, ...
Journal of clinical oncology 29 (23), 3120, 2011
2202011
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib+ chemotherapy-Cancer and Leukemia Group B Trial 30203
MJ Edelman, D Watson, X Wang, C Morrison, RA Kratzke, S Jewell, ...
Journal of Clinical Oncology 26 (6), 848-855, 2008
2052008
Epigenetics of lung cancer
SM Langevin, RA Kratzke, KT Kelsey
Translational Research 165 (1), 74-90, 2015
1982015
Immunohistochemical Analysis of the p16INK4 Cyclin-Dependent Kinase Inhibitor in Malignant Mesothelioma
RA Kratzke, GA Otterson, CE Lincoln, S Ewing, H Oie, J Geradts, FJ Kaye
JNCI: Journal of the National Cancer Institute 87 (24), 1870-1875, 1995
1721995
The system can't perform the operation now. Try again later.
Articles 1–20